Perhaps no corneal condition is more vexing than recurrent corneal erosion (RCE). While the causes vary, the treatment options have remained virtually unchanged for quite some time, at least until recently. Today, amniotic membranes have gained popularity as an alternate treatment for RCE.
One day, genetic testing and gene therapy may help patients avoid corneal disease altogether.
The elaborate tear film ecosystem has to maintain its own delicate balance, despite influences from many outside sources and intrinsic characteristics. Dry eye is one such condition to disrupt the balance, giving rise to its newer moniker,dysfunctional tear film
. It likely results from a host of factors, including hormone imbalance.
Timely information on these issues is at our fingertips, thanks to the CDC.
The next step in a legislative confrontation may mean better protection for lens wearers.
Though the main treatment for ectasia remains contact lens use, a new procedure could ease the fitting ordeal.
Are you doing everything you can to make life easier for your keratoconus patients?
Though sclerals are widely used today, is there any peril to their growing popularity?
“Data on demand” could revolutionize the care of patients with diabetes or glaucoma.
If you are like most of us, decreasing tension in 2016 is a laudable New Years' resolution.
Not all drugs are created equal. Be aware of these potential differences.
The CDC's latest MMWR reveals that contact lens compliance is embarrassingly low. What can we do about it?
The recent passing of Professor Brien Holden highlights the continuing need for myopia research.
The connection between ocular surface disease and certain negative stimuli may be greater than previously thought.
The ubiquity of information online is both a blessing and a curse. How much knowledge is too much?
We have made huge strides in understanding dry eye disease, with more on the way.
In an age of narrowly targeted pharmaceutical indications, this decades-old drug is surprisingly versatile.
Ocular concerns differ somewhat from systemic ones, but in many respects the risks and consequences are comparable.
Watch out for third-party contact lens sellers attempting to gain your patients' business.
The CDC offers a helping hand to eye care practitioners. Let's take it!
Your clinical decisions and any professional involvement with industry are about to receive unprecedented scrutiny.
Novel drug delivery methods were on display at this year's annual ARVO meeting.
We must be on the lookout for limbal stem cell deficiency early in its course, especially in contact lens wearers, to avoid the need for surgical intervention.
Are omega-3 fatty acids beneficial or deleterious to the health of our patients? Faced with inconclusive data, how should we proceed?